Michael Ankersen

1.5k total citations
38 papers, 1.2k citations indexed

About

Michael Ankersen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Michael Ankersen has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 14 papers in Endocrine and Autonomic Systems. Recurrent topics in Michael Ankersen's work include Growth Hormone and Insulin-like Growth Factors (16 papers), Regulation of Appetite and Obesity (14 papers) and Biochemical Analysis and Sensing Techniques (7 papers). Michael Ankersen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (16 papers), Regulation of Appetite and Obesity (14 papers) and Biochemical Analysis and Sensing Techniques (7 papers). Michael Ankersen collaborates with scholars based in Denmark, United States and Switzerland. Michael Ankersen's co-authors include Birgitte Holst, Adam I. Cygankiewicz, Thue W. Schwartz, Birgit Sehested Hansen, Henning Thøgersen, Kirsten Raun, Kent Bondensgaard, Carsten E. Stidsen, Robert P. Bywater and Birgitte S. Wulff and has published in prestigious journals such as Journal of the American Chemical Society, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Michael Ankersen

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Ankersen Denmark	16	586	432	399	329	255	38	1.2k
Akira Gomori Japan	17	498 0.8×	274 0.6×	308 0.8×	233 0.7×	134 0.5×	25	1.1k
Beth A. Fleck United States	19	378 0.6×	341 0.8×	400 1.0×	118 0.4×	30 0.1×	51	910
Blair Weig United States	14	241 0.4×	200 0.5×	320 0.8×	115 0.3×	25 0.1×	20	711
Jun‐ichi Eiki Japan	17	230 0.4×	89 0.2×	791 2.0×	227 0.7×	423 1.7×	28	1.3k
Bharat Shimpukade Denmark	12	60 0.1×	195 0.5×	559 1.4×	186 0.6×	218 0.9×	15	962
Michael E. Brune United States	18	113 0.2×	74 0.2×	251 0.6×	80 0.2×	155 0.6×	41	746
Malliga R. Iyer United States	23	120 0.2×	57 0.1×	426 1.1×	141 0.4×	128 0.5×	63	1.3k
James J. Knittel United States	14	125 0.2×	200 0.5×	414 1.0×	47 0.1×	39 0.2×	31	840
Ramakrishna Seethala United States	19	90 0.2×	49 0.1×	629 1.6×	88 0.3×	211 0.8×	36	1.2k
Jill M. McFadden United States	13	166 0.3×	55 0.1×	790 2.0×	213 0.6×	73 0.3×	17	1.3k

Countries citing papers authored by Michael Ankersen

Since Specialization

Citations

This map shows the geographic impact of Michael Ankersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ankersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ankersen more than expected).

Fields of papers citing papers by Michael Ankersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ankersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ankersen. The network helps show where Michael Ankersen may publish in the future.

Co-authorship network of co-authors of Michael Ankersen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ankersen. A scholar is included among the top collaborators of Michael Ankersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ankersen. Michael Ankersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blevins, Thomas, Abhijit Barve, Bin Sun, & Michael Ankersen. (2018). Efficacy and safety of MYL‐1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study. Diabetes Obesity and Metabolism. 20(8). 1944–1950. 20 indexed citations

Blevins, Thomas, et al.. (2018). Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study. Diabetes Obesity and Metabolism. 21(1). 129–135. 18 indexed citations

Conde‐Frieboes, Kilian W., Michael Ankersen, Jens Breinholt, et al.. (2011). Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Bioorganic & Medicinal Chemistry Letters. 21(5). 1459–1463. 6 indexed citations

Østergaard, Jesper, et al.. (2010). Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration. Drug Development and Industrial Pharmacy. 37(1). 62–71. 1 indexed citations

Larsen, Susan Weng, Michael Ankersen, & Claus Larsen. (2004). Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe). European Journal of Pharmaceutical Sciences. 22(5). 399–408. 21 indexed citations

Lau, Jesper, et al.. (2003). Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor. Bioorganic & Medicinal Chemistry Letters. 14(2). 317–320. 17 indexed citations

Larsen, Susan Weng, et al.. (2003). Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde. European Journal of Pharmaceutical Sciences. 20(2). 233–240. 18 indexed citations

Ankersen, Michael. (2002). 4 Growth Hormone Secretagogues: Discovery of Small Orally Active Molecules by Peptidomimetic Strategies. Progress in medicinal chemistry. 39. 173–214. 6 indexed citations

Peschke, Bernd, Michael Ankersen, Michael Bauer, et al.. (2002). The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency. European Journal of Medicinal Chemistry. 37(6). 487–501. 7 indexed citations

10.

Hansen, Thomas K., Michael Ankersen, Kirsten Raun, & Birgit Sehested Hansen. (2001). Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin. Bioorganic & Medicinal Chemistry Letters. 11(14). 1915–1918. 7 indexed citations

11.

Malmlöf, Kjell, et al.. (2001). Daily Low-Dose Administration of Growth Hormone Secretagogue Stimulates Pulsatile Growth Hormone Secretion and Elevates Plasma Insulin-like Growth Factor-1 Levels in Pigs. Endocrine. 16(3). 195–200. 8 indexed citations

12.

Tullin, Søren, et al.. (2000). Adenosine Is an Agonist of the Growth Hormone Secretagogue Receptor. Endocrinology. 141(9). 3397–3402. 55 indexed citations

13.

Ankersen, Michael, Karin Kramer Nielsen, Thomas Kruse Hansen, Kirsten Raun, & Birgit Sehested Hansen. (2000). Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal. European Journal of Medicinal Chemistry. 35(5). 487–497. 15 indexed citations

14.

Crider, A. Michael, et al.. (1999). 2-Pyridylthioureas: Novel Nonpeptide Somatostatin Agonists with SST4 Selectivity. Current Pharmaceutical Design. 5(4). 255–263. 14 indexed citations

15.

Raun, Kirsten, et al.. (1999). Pharmacological characterisation of a new oral GH secretagogue, NN703. European Journal of Endocrinology. 141(2). 180–189. 50 indexed citations

16.

Liu, Shenquan, et al.. (1999). ChemInform Abstract: Nonpeptide Somatostatin Agonists with sst₄ Selectivity: Synthesis and Structure—Activity Relationships of Thioureas.. ChemInform. 30(13). 15 indexed citations

17.

Raun, Kirsten, Birgit Sehested Hansen, Niklas Dyrby Johansen, et al.. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 139(5). 552–561. 79 indexed citations

18.

Ankersen, Michael, Bernd Peschke, Birgit Sehested Hansen, & Thomas Kruse Hansen. (1997). INVESTIGATION OF BIOISOSTERS OF THE GROWTH HORMONE SECRETAGOGUE L-692,429.. Bioorganic & Medicinal Chemistry Letters. 7(10). 1293–1298. 42 indexed citations

19.

Ankersen, Michael, Alexander Senning, Risto S. Laitinen, & Otto Dahl. (1989). Aspirin Prodrugs: Synthesis and Hydrolysis of 2-Benzyloxy-2-methyl-4H-1,3-benzodioxin-4-ones.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 43(8). 793–798. 9 indexed citations

20.

Ankersen, Michael, Karin Kramer Nielsen, Alexander Senning, et al.. (1989). Synthesis, Properties and Prodrug Potential of 2-Methyl-2-oxy- and 2-Methyl-2-thio-4H-1,3-benzodioxin-4-ones.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 43(3). 213–221. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact